IP Verse

Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Newcastle Disease Virus Antigens - EP2768964

The patent EP2768964 was granted to Intervet on Oct 10, 2018. The application was originally filed on Oct 19, 2012 under application number EP12775246A. The patent is currently recorded with a legal status of "Revoked".

EP2768964

INTERVET
Application Number
EP12775246A
Filing Date
Oct 19, 2012
Status
Revoked
Dec 6, 2024
Grant Date
Oct 10, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USAJul 9, 2019D YOUNG -

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1298139
DESCRIPTIONUS5187087
DESCRIPTIONUS5830745
DESCRIPTIONUS5834305
DESCRIPTIONUS5853733
DESCRIPTIONUS5928648
DESCRIPTIONUS5961982
DESCRIPTIONUS5965138
DESCRIPTIONUS5980906
DESCRIPTIONUS6121043
DESCRIPTIONUS6183753
DESCRIPTIONUS6299882
DESCRIPTIONUS6875856
DESCRIPTIONUS6913751
DESCRIPTIONWO2010125084
DESCRIPTIONWO8704463
DESCRIPTIONWO9203554
INTERNATIONAL-SEARCH-REPORTUS5853733
INTERNATIONAL-SEARCH-REPORTUS5965138
INTERNATIONAL-SEARCH-REPORTUS6033670
INTERNATIONAL-SEARCH-REPORTWO0061736
OPPOSITIONUS5266489
OPPOSITIONUS5853733
OPPOSITIONUS6913751
OPPOSITIONWO0061736
OPPOSITIONWO2010119112
OPPOSITIONWO2013057235
OPPOSITIONWO2013057236
OPPOSITIONWO2013082327
OPPOSITIONWO9325665
OPPOSITIONWO9605291
OPPOSITIONWO9837216

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- Declaration by S.M. Cook (19-10-2012)
OPPOSITION- ARMOUR et al., "Current and Future Applications of Viral-Vectored Recombinant Vaccines in Poultry", Poultry informed professional, (20140000), no. 134, pages 1 - 12, XP055621433
OPPOSITION- CANTELLO et al., "ISOLATION OF A MAREK'S DISEASE VIRUS (MDV) RECOMBINANT CONTAINING THE LACZ GENE OF ESCHERICHIA COLI STABLY INSERTTED WITHIN THE MDV US2 GENE", Journal of virology, (19910000), vol. 65, no. 3, pages 1584 - 1588, XP000283115
OPPOSITION- Karel Antoni Schat, "Back to the past: do vector vaccines represent the future?", (20150000), pages 1 - 12, XP055462411
OPPOSITION- LUCCHESE et al., "How a single amino acid change may alter the immunological information of a peptide", Frontiers in bioscience, (20120000), vol. E4, pages 1843 - 1852, XP009190790
OPPOSITION- ROSS, "Recombinant vaccines against Marek`s disease", Avian pathology, (19980000), vol. 27, pages S65 - S73, XP055621430
OPPOSITION- TAYLOR et al., "Efficacy of a Recombinant Fowl Pox-Based Newcastle Disease Virus Vaccine Candidate against Velogenic and Respiratory Challenge", Avian diseases, (19960000), vol. 40, pages 173 - 180, XP055621412
OPPOSITION- WITTER et al., "Poultry Vaccines of the future", Poultry science, (19940000), vol. 73, no. 7, pages 1087 - 1093, XP055621406
OPPOSITION- YANAGIDA et al., "RECOMBINANT FOWLPOX VIRUSES EXPRESSING THE GLYCOPROTEIN B HOMOLOG AND THE PP38 GENE OF MAREK'S DISEASE VIRUS", Journal of virology, (19920000), vol. 66, no. 3, pages 1402 - 1408, XP000616407
OPPOSITION- TSUKAMOTO et al., "Protection of Chickens against Very Virulent Infectious Bursal Disease Virus (IBDV) and Marek's Disease Virus (MDV) with a Recombinant MDV Expressing IBDV VP2", Virology, (19990000), vol. 257, pages 352 - 362, XP004439947
OPPOSITION- REDDY et al., "PROTECTIVE EFFICACY OF A RECOMBINANT HERPESVIRUS OF TURKEYS AS AN IN OVO VACCINE AGAINST NEWCASTLE AND MAREK'S DISEASES IN SPECIFIC-PATHOGEN-FREE CHICKENS", Vaccine, (19960000), vol. 14, no. 6, pages 469 - 477, XP000616405
OPPOSITION- Mark W. JACKWOOD, "Current and Future Recombinant Viral Vaccines for Poultry", Advances in veterinary medicine, (19990000), vol. 41, pages 517 - 522, XP055621420
OPPOSITION- SUN et al., "Construction and Characterization of Recombinant Fowlpox Virus Co-expressing F and HN Genes of Newcastle Disease Virus and gB Gene of Infectious Larygnotracheitis Virus", Chinese journal of biotechnology, (20060000), vol. 22, no. 6, pages 931 - 939, XP022857395
OPPOSITION- QIAO et al., "Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes", Avian pathology, (20030000), vol. 32, pages 25 - 31, XP009109633
OPPOSITION- VAGNOZZI et al., "Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens", Avian pathology, (20111017), vol. 41, no. 1, pages 21 - 31, XP055096023
OPPOSITION- SONODA et al., "Development of an Effective Polyvalent Vaccine against both Marek's and Newcastle Diseases Based on Recombinant Marek's Disease Virus Type 1 in Commercial Chickens with Maternal Antibodies", Journal of virology, (20000000), vol. 74, no. 7, pages 3217 - 3226, XP002624694
OPPOSITION- GAO et al., "Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site", PLoS ONE, (20110000), vol. 6, no. 7, pages e22549-1 - e22549-9, XP055462416
OPPOSITION- SUN et al., "Protection of Chickens from Newcastle Disease and Infectious Laryngotracheitis with a Recombinant Fowlpox Virus Co-Expressing the F, HN Genes of Newcastle Disease Virus and gB Gene of Infectious Laryngotracheitis Virus", Avian diseases, (20080000), vol. 52, pages 111 - 117, XP002692579
OPPOSITION- JOHNSON et al., "Protection Against Infectious Laryngotracheitis by In Ovo Vaccination with Commercially Available Viral Vector Recombinant Vaccines", Avian diseases, (20100000), vol. 54, no. 4, pages 1251 - 1259, XP008166663
OPPOSITION- HECKERT et al., "Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens", Avian diseases, (19960000), vol. 40, pages 770 - 777, XP009193341

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents